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Abstract: We assessed 12 urine metals in tobacco smoke-exposed and not exposed National 
Health and Nutrition Examination Survey participants. Our analysis included age, 
race/ethnicity, and poverty status. Gender and racial/ethnic differences in cadmium and lead 
and creatinine-adjusted and unadjusted data for group comparisons are presented. Smokers’ 
had higher cadmium, lead, antimony, and barium levels than nonsmokers. Highest lead 
levels were in the youngest subjects. Lead levels among adults with high second-hand 
smoke exposure equaled smokers. Older smokers had cadmium levels signaling the 
potential for cadmium-related toxicity. Given the potential toxicity of metals, our findings 
complement existing research on exposure to chemicals in tobacco smoke. 
Keywords: secondhand smoke (SHS); metals; youth; lead; cadmium; race/ethnicity; 
tobacco smoke; smoker; toxicity 
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1. Introduction 
 
Cigarette smoke inhaled by a smoker contains more than 4,000 chemicals [1], and second hand 
smoke (SHS) is qualitatively similar [1]. Metals in tobacco smoke are of public health concern because 
of their potential toxicity and carcinogenicity [2]. Some are linked to adverse health outcomes such as 
cardiovascular and renal disease and impaired lung function among smokers [3-7]. Because the dose of 
toxic chemicals received by a smoker is an important factor in the harm caused by tobacco, analysis of 
the National Health and Nutrition Examination Survey (NHANES) exposure data suggests promising 
candidate chemicals for determining whether reductions of certain toxic constituents in cigarettes and 
cigarette smoke translate into reductions in active and passive smokers’ exposure to these substances. 
Prevention of tobacco use and SHS exposure remains a critically important public health priority. 
The Surgeon General recently concluded that there is no safe level of SHS exposure [1,8]. Although 
significant progress has been made to reduce SHS exposure, nearly half (46.4%) of U.S. nonsmokers 
remain exposed [9]. 
The NHANES is a vital source of population-level exposure data for environmental pollutants, 
including tobacco smoke. Population-level data is important to assess the magnitude of various 
exposures and the impact of laws and policies aimed at tobacco use and SHS exposure [2,10]. All 12 
of the metals in this study (antimony (Sb), barium (Ba), beryllium (Be), cadmium (Cd), cesium (Cs), 
cobalt (Co), lead (Pb), mercury (Hg), molybdenum (Mo), platinum (Pt), thallium (Tl), and  
tungsten (W)) have been reported in tobacco smoke [11,12]. Some metals, such as cadmium and lead, 
are widely recognized for their toxicity and tendency to accumulate in the body [13,14].
 
While noting 
that no one threshold for all adverse effects from lead exposure has been demonstrated, and that the 
available evidence has important limitations including the small number of studies of peak blood lead 
levels below 10 µg/dL in children never known to have a blood lead level exceeding 10 µg/dL, the 
CDC has concluded that the data demonstrates that no level of lead in a child’s blood can be specified 
as safe [15,16]. Other metals, such as cobalt, have beneficial or harmful effects, depending on the level 
of exposure [17]. 
This study examined levels of urinary metals among cigarette smoke exposed and not exposed 
NHANES participants. Unlike previous studies that focused on a select few metals [5,6], we included 
12 metals to provide population-level, baseline exposure data for a large number of potentially toxic 
metals. We analyzed urine data because, while influenced by pharmacokinetics, urine measurements 
are a useful noninvasive approach in biomonitoring research of exposures to metals and other 
environmental pollutants [18-21]. The findings from this study contribute to the limited information 
available regarding exposure to potentially toxic metals in tobacco smoke. By analyzing data for both 
active and passive smokers, we provide information to strengthen public health messages regarding 
quitting smoking, to increase awareness of the dangers of SHS exposure, and the need for strategies to 
further reduce SHS exposure.  
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2. Results and Discussion 
 
The unweighted sample by demographic characteristic is presented for all metals (Table 1). 
Approximately equal numbers of males and females are present among participants and most were 
above the poverty threshold. 
 
Table 1. Sample Size by Demographic Characteristics for 12 Urinary Metals. 
Demographic 
Characterisitics Cd Pb Hg Sb Ba Be Cs Co Mo Pt Tl W 
Total 6,043 6,270 1,422 6,110 6,031 6,270 6,270 6,270 6,102 6,270 6,200 6,137 
AGE(years)  
2:[6–12) 776 834 n/aa  815 796 834 834 834 807 834 824 813 
3:[12–19) 1,461 1,523 297 1,485 1,450 1,523 1,523 1,523 1,477 1,523 1,499 1,483 
4:[19–35) 1,077 1,103 626 1,074 1,071 1,103 1,103 1,103 1,084 1,103 1,091 1,079 
5:[35–50) 918 939 499 912 913 939 939 939 919 939 938 925 
6:[50–65) 800 822 n/a  797 786 822 822 822 802 822 811 803 
7:[65+) 1,011 1,049  n/a 1,027 1,015 1,049 1,049 1,049 1,013 1,049 1,037 1,034 
RACE/ETHNICITY 
Non-Hispanic 
White 2,453 2,532 583 2,485 2,480 2,532 2,532 2,532 2,477 2,532 2,500 2,502 
Non-Hispanic 
Black 1,477 1,511 329 1,498 1,488 1,511 1,511 1,511 1,493 1,511 1,498 1,492 
Mexican 
American 1,712 1,809 400 1,728 1,649 1,809 1,809 1,809 1,729 1,809 1,786 1,730 
GENDER                         
Male 2,937 3,052 n/a  2,971 2,933 3,052 3,052 3,052 2,966 3,052 3,016 2,978 
Female 3,106 3,218 1,422 3,139 3,098 3,218 3,218 3,218 3,136 3,218 3,184 3,159 
POVERTY INDEX  
Below 
poverty index 1,339 1,403 352 1,369 1,350 1,403 1,403 1,403 1,354 1,403 1,381 1,381 
Above 
poverty index 4,220 4,360 967 4,257 4,215 4,360 4,360 4,360 4,259 4,360 4,320 4,269 
a 
Data not available for this group. 
 
Table 2 shows the creatinine adjusted and unadjusted geometric mean levels for the overall 
population and the four exposure groups (unexposed nonsmokers (nonsmokers); nonsmokers with low 
SHS exposure (nonsmokerslow); nonsmokers with high SHS exposure (nonsmokershigh); and self-
identified cigarette smokers (smokers)).  
Nonsmokerslow had significantly higher lead (adjusted; p < 0.05 and unadjusted; p < 0.001) and 
antimony (unadjusted; p < 0.01) levels than nonsmokers. There was no significant difference in levels 
of urine cadmium, barium, cesium, cobalt, molybdenum, platinum, thallium, or tungsten for 
nonsmokerslow and nonsmokers (Table 2).  
 
 
 
 
Int. J. Environ. Res. Public Health 2009, 6         
 
 
1933 
Table 2. Geometric Means and P-values Overall and by Level of Smoke Exposure for 12 
Urinary Metals. 
Metal 
Creatinine 
Adjustment 
Overall  
Geometric Mean 
metal level 
Nonsmokers Smokers 
P-valuea 
Geometric Mean 
metal level 
without SHS 
Geometric Mean 
metal level with 
Low SHS 
Geometric Mean 
metal level with 
High SHS 
Geometric Mean 
metal level 
Cadmium Adjustedb 0.22 (0.21,0.23) 0.21 (0.20,0.22) 0.20 (0.18,0.21)e 0.16 (0.14,0.17)f 0.34 (0.30,0.37)f 0.0000 
Cadmium Unadjustedc 0.22 (0.21,0.23) 0.20 (0.19,0.21) 0.21 (0.19,0.23)d 0.17 (0.15,0.19)f 0.37 (0.34,0.41)f 0.0000 
          
Lead Adjusted 0.66 (0.64,0.68) 0.61 (0.58,0.63)d 0.67 (0.64,0.70) 0.68 (0.62,0.73) 0.73 (0.69,0.78)f 0.0001 
Lead Unadjusted 0.67 (0.65,0.70) 0.58 (0.55,0.60)f 0.69 (0.64,0.75) 0.74 (0.66,0.82) 0.82 (0.76,0.89)f 0.0000 
          
Mercury Adjusted 0.65 (0.60,0.71) 0.75 (0.66,0.85)d 0.60 (0.53,0.67) 0.62 (0.46,0.77) 0.57 (0.51,0.63)e 0.0053 
Mercury Unadjusted 0.64 (0.57,0.72) 0.67 (0.57,0.78) 0.59 (0.47,0.71) 0.77 (0.56,0.98) 0.58 (0.48,0.67)  
          
Antimony Adjusted 0.11 (0.10,0.12) 0.11 (0.10,0.11) 0.11 (0.10,0.12) 0.11 (0.10,0.12) 0.11 (0.10,0.12)   
Antimony Unadjusted 0.11 (0.11,0.12) 0.10 (0.10,0.11)e 0.11 (0.11,0.12) 0.12 (0.11,0.13) 0.13 (0.12,0.14)f 0.0000 
          
Barium Adjusted 1.43 (1.36,1.50) 1.42 (1.34,1.50) 1.43 (1.32,1.55) 1.47 (1.30,1.63) 1.42 (1.31,1.54)   
Barium Unadjusted 1.47 (1.39,1.55) 1.34 (1.26,1.43) 1.50 (1.36,1.64) 1.60 (1.39,1.81) 1.60 (1.44,1.75)e 0.0019 
          
Beryllium Adjusted 0.09 (0.08,0.09) 0.09 (0.09,0.10)e 0.08 (0.08,0.09) 0.08 (0.07,0.09) 0.08 (0.07,0.08)f 0.0000 
Beryllium Unadjusted 0.09 (0.09,0.09) 0.09 (0.09,0.09) 0.09 (0.09,0.09) 0.09 (0.09,0.09) 0.09 (0.09,0.09)   
          
Cesium Adjusted 4.47 (4.35,4.59) 4.86 (4.67,5.05)e 4.42 (4.25,4.59)d 4.07 (3.85,4.28) 4.08 (3.93,4.24)f 0.0000 
Cesium Unadjusted 4.57 (4.37,4.77) 4.60 (4.34,4.87) 4.60 (4.25,4.95) 4.45 (4.07,4.82) 4.57 (4.28,4.87)   
          
Cobalt Adjusted 0.34 (0.33,0.35) 0.35 (0.33,0.37) 0.34 (0.32,0.35) 0.35 (0.33,0.38)e 0.32 (0.29,0.34)d 0.0063 
Cobalt Unadjusted 0.35 (0.33,0.37) 0.33 (0.31,0.35) 0.35 (0.32,0.38) 0.39 (0.35,0.42) 0.35 (0.32,0.38) 0.0246 
        
Molybdenum Adjusted 41.69(40.19,43.18) 46.33(44.20,48.47) 42.79(40.29,45.29) 41.89(38.86,44.93)d 32.67(30.77,34.56)d  0.0000 
Molybdenum Unadjusted 42.71(40.66,44.76) 43.92(41.35,46.49) 44.63(40.48,48.78) 45.83(40.94,50.72)d 36.53(33.25,39.81)d 0.0032 
          
Platinum Adjusted 0.03 (0.03,0.04) 0.04 (0.04,0.04) 0.03 (0.03,0.04) 0.03 (0.03,0.03) 0.03 (0.03,0.03)e 0.0027 
Platinum Unadjusted 0.04 (0.03,0.04) 0.04 (0.03,0.04) 0.04 (0.03,0.04) 0.04 (0.03,0.04) 0.04 (0.03,0.04)  
          
Thallium Adjusted 0.16 (0.16,0.16) 0.17 (0.16,0.17) 0.16 (0.16,0.17) 0.16 (0.15,0.17)f 0.14 (0.13,0.14)f 0.0000 
Thallium Unadjusted 0.16 (0.16,0.17) 0.16 (0.15,0.17) 0.17 (0.16,0.18) 0.17 (0.16,0.19) 0.15 (0.14,0.16)   
          
Tungsten Adjusted 0.08 (0.07,0.08) 0.08 (0.07,0.08) 0.08 (0.07,0.08) 0.08 (0.07,0.09) 0.07 (0.06,0.08)  
Tungsten Unadjusted 0.08 (0.07,0.08) 0.07 (0.07,0.08) 0.08 (0.07,0.09) 0.09 (0.08,0.10) 0.08 (0.07,0.09) 0.0240 
a 
A statistically significant difference in log transformed mean levels between the exposure groups 
(nonsmoker, nonsmokerlow, nonsmokerhigh, smoker) determined by linear regression.  
b 
Units are µg/g creatinine.
  
c 
Units are µg/L. 
For statistical analysis of differences in mean urine metal levels the following t-tests comparisons were 
performed: nonsmokers and nonsmokerslow; nonsmokerslow and nonsmokershigh; nonsmokershigh and 
smokers; smokers and nonsmokers; 
d
 p-value less than 0.05;  
e
 p-value less than 0.01;  
f
 p-value less than 0.001. 
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Smokers had higher cadmium, lead (p < 0.001), antimony (unadjusted; p < 0.001), and barium 
(unadjusted; p < 0.01) levels than nonsmokers. Levels of some metals, including essential metals 
cobalt (adjusted; p < 0.05) and molybdenum (p < 0.05), were lower in smokers (Table 2).  
Table 3 presents adjusted and unadjusted geometric mean cadmium levels for exposure groups by 
age, race/ethnicity, gender, and poverty status. Cadmium levels generally increased with age in the 
overall population and in each exposure group. Except for 65 and older nonsmokershigh that had a 
higher urine cadmium than nonsmokerslow (adjusted; p < 0.01), nonsmokers did not have an increase in 
urine cadmium across the exposure groups. Smokers 19–35 (adjusted; p < 0.05 and unadjusted;  
p < 0.001), 35-50 (p < 0.001), 50-65 (p < 0.001), and 65 and older (p < 0.001) had higher levels than 
did similarly aged nonsmokers. Levels in smokers 35-50, 50-65, and 65 years and older were also 
higher than levels in nonsmokershigh (p < 0.001). Smokers in all racial/ethnic groups had higher levels 
than nonsmokers (p < 0.001).  
 
Table 3. Geometric Means and P-values Overall and by Level of Smoke Exposure and by 
Demographic Characteristics for Cadmium (Cd). 
Demographic 
Characteristics 
Creatinine 
Adjustment 
Overall  
Geometric 
Mean Cd level 
Nonsmokers Smokers 
P-valuea 
Geometric 
Mean Cd level 
without SHS 
Geometric 
Mean Cd level 
with Low SHS 
Geometric 
Mean Cd level 
with High SHS 
Geometric 
Mean Cd level  
AGE(years) 
2:[6–12)b Adjustedc 
0.09 
(0.08,0.10) 0.08 (0.07,0.10) 0.09 (0.07,0.10) 0.09 (0.08,0.11) n/ad    
  Unadjustede 
0.08 
(0.07,0.09) 0.08 (0.06,0.09) 0.08 (0.06,0.10) 0.08 (0.07,0.10) n/a   
3:[12–19) Adjusted 
0.09 
(0.08,0.09) 0.09 (0.08,0.10) 0.09 (0.08,0.10) 0.08 (0.07,0.09) 0.08 (0.07,0.10)  
  Unadjusted 
0.12 
(0.11,0.13) 0.11 (0.10,0.13) 0.13 (0.11,0.15) 0.12 (0.11,0.14) 0.12 (0.09,0.15)  
4:[19–35) Adjusted 
0.14 
(0.13,0.15) 0.14 (0.13,0.15) 0.11 (0.09,0.13) 0.13 (0.11,0.15) 0.18(0.16,0.20)f 0.0005 
  Unadjusted 
0.18 
(0.17,0.20) 0.16 (0.14,0.18) 0.14 (0.10,0.17) 0.19 (0.15,0.22) 0.24(0.20,0.27)h 0.0002 
5:[35–50) Adjusted 
0.27 
(0.25,0.29) 0.21 (0.19,0.23) 0.24 (0.20,0.27) 0.22(0.18,0.26)h 0.45(0.40,0.50)h 0.0000 
  Unadjusted 
0.28 
(0.25,0.30) 0.21 (0.18,0.24) 0.26 (0.22,0.29) 0.22(0.17,0.27)h 0.45(0.39,0.50)h 0.0000 
6:[50–65) Adjusted 
0.40 
(0.37,0.43) 0.33 (0.30,0.37) 0.38 (0.31,0.45) 0.36(0.30,0.42)h 0.67(0.58,0.76)h 0.0000 
  Unadjusted 
0.35 
(0.32,0.39) 0.28 (0.25,0.32) 0.34 (0.27,0.41) 0.30(0.19,0.41)h 0.65(0.54,0.76)h 0.0000 
7:[65+) Adjusted 
0.46 
(0.43,0.49) 0.43 (0.39,0.46) 0.40(0.36,0.43)g 0.54(0.46,0.63)h 1.04(0.90,1.18)h 0.0000 
  Unadjusted 
0.36 
(0.33,0.39) 0.31 (0.28,0.35) 0.35 (0.29,0.40) 0.43(0.34,0.51)h 0.90(0.72,1.08)h 0.0000 
RACE/ETHNICITY 
Non-
Hispanic 
White Adjusted 
0.23 
(0.21,0.24) 0.22 (0.20,0.23) 0.21(0.18,0.24)g 0.15(0.14,0.17)h 0.34(0.30,0.38)h 0.0000 
  Unadjusted 
0.22 
(0.20,0.23) 0.20 (0.18,0.21) 0.20(0.18,0.23)f 0.16(0.14,0.18)h 0.34(0.30,0.38)h 0.0000 
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Table 3. Cont. 
Non-
Hispanic 
Black Adjusted 
0.20 
(0.18,0.21)j 0.19 (0.17,0.22) 0.16 (0.14,0.18)i 
0.15 
(0.13,0.17)h 
0.36 
(0.30,0.42)h 0.0000 
  Unadjusted 
0.29 
(0.26,0.32)k 0.27 (0.23,0.32)j 0.23 (0.20,0.26) 
0.21 
(0.18,0.24)h,j 
0.60 
(0.50,0.70)h,k 0.0000 
Mexican 
American Adjusted 
0.18 
(0.16,0.19)k  
0.17 
(0.16,0.19)k 0.16 (0.14,0.18)j 
0.15 
(0.12,0.17)h 
0.28 
(0.23,0.34)h 0.0000 
  Unadjusted 
0.19 
(0.18,0.21)i 0.17 (0.16,0.19)i 0.18 (0.16,0.21) 
0.16 
(0.13,0.19)h 
0.36 
(0.30,0.41)h 0.0000 
GENDER 
Male Adjusted 
0.18 
(0.17,0.19) 0.16 (0.15,0.17) 0.16 (0.14,0.18) 
0.13 
(0.12,0.15)h 
0.29 
(0.25,0.32)h 0.0000 
  Unadjusted 
0.22 
(0.21,0.23) 0.19 (0.18,0.21) 0.20 (0.17,0.23) 
0.16 
(0.13,0.18)h 
0.38 
(0.33,0.43)h 0.0000 
Female Adjusted 
0.26 
(0.25,0.28)k 
0.26 
(0.24,0.27)k 
0.25 
(0.22,0.28)h,k 
0.18 
(0.16,0.20)h,k 
0.40 
(0.35,0.45)h,k 0.0000 
  Unadjusted 
0.23 
(0.21,0.24) 0.20 (0.19,0.22) 0.21 (0.19,0.24) 
0.19 
(0.16,0.21)h 
0.37 
(0.32,0.42)h 0.0000 
POVERTY INDEX 
Below 
poverty index Adjusted 
0.20 
(0.18,0.21) 0.19 (0.17,0.22) 0.17 (0.14,0.20) 
0.14 
(0.12,0.16)h 
0.31 
(0.27,0.36)h 0.0000 
  Unadjusted 
0.23 
(0.20,0.25) 0.19 (0.16,0.22) 0.21 (0.17,0.25) 
0.16 
(0.14,0.18)h 
0.40 
(0.33,0.47)h 0.0000 
Above 
poverty index Adjusted 
0.22 
(0.21,0.23) 0.21 (0.20,0.22) 
0.20 
(0.18,0.22)g 
0.16 
(0.14,0.17)h 
0.34 
(0.30,0.38)h 0.0000 
  Unadjusted 
0.22 
(0.21,0.23) 0.20 (0.18,0.21) 0.20 (0.18,0.23) 
0.17 
(0.15,0.19)h 
0.37 
(0.32,0.42)h 0.0000 
a 
A statistically significant difference in log transformed mean levels between the exposure groups 
(nonsmoker, nonsmokerlow, nonsmokerhigh, smoker) determined by linear regression. 
b
 For age categories, a square bracket indicates inclusion of the interval end point, and a parenthesis 
indicates exclusion. 
c 
Units are µg/g creatinine.
  
d 
Not applicable.
 
e 
Units are µg/L. 
For statistical analysis of differences in mean urine metal levels the following t-tests comparisons were 
performed: nonsmokers and nonsmokerslow; nonsmokerslow and nonsmokershigh; nonsmokershigh and 
smokers; smokers and nonsmokers; and nonsmoker vs. nonsmokerhigh for children aged 6–11 years;  
f
 p-value less than 0.05; 
g
 p-value less than 0.01; 
h
 p-value less than 0.001. For statistical analysis of 
differences in mean urine cadmium levels across group comparisons, the following t-test comparisons 
were performed: non-Hispanic black versus non-Hispanic white, Mexican American versus non-Hispanic 
white, and female versus male; 
i
 p-value less than 0.05; 
j
 p-value less than 0.01; 
k
 p-value less than 0.001. 
 
Analysis of unadjusted data show that, except for nonsmokerslow, non-Hispanic blacks had higher 
cadmium levels than non-Hispanic whites (nonsmokers, p < 0.01; nonsmokerhigh, p < 0.01; smokers,  
p < 0.001). When means were creatinine adjusted, non-Hispanic blacks had lower or similar levels 
than non-Hispanic whites. Mexican Americans overall (adjusted; p < 0.001 and unadjusted; p < 0.05), 
Mexican American nonsmokers (adjusted; p < 0.001 and unadjusted; p < 0.05), and Mexican 
American nonsmokerslow (adjusted; p < 0.01) had lower urine cadmium levels than  
non-Hispanic whites.  
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Male and female smokers had higher adjusted and unadjusted cadmium levels than nonsmokers  
(p < 0.001). Male and female nonsmokers did not have an increase in urine cadmium across the 
exposure groups. Females (all exposure groups) had higher adjusted levels than males (p < 0.001). 
Levels of cadmium in the urine of smokers above and below the poverty threshold were higher than 
levels of nonsmokers (p < 0.001). Nonsmokers above and below the poverty threshold did not have an 
increase in urine cadmium across the exposure groups. 
Table 4 presents adjusted and unadjusted geometric mean lead levels for all exposure groups by 
age, race/ethnicity, gender, and poverty status. Among 6-12 year olds, nonsmokershigh had higher 
levels than nonsmokers (adjusted; p < 0.001 and unadjusted; p < 0.05) or nonsmokerslow (adjusted;  
p < 0.01). Excluding youth 6-12 years, levels generally increased with age in the overall population 
and for all exposure groups. Although 12-19 year old nonsmokerslow (adjusted; p < 0.05 and 
unadjusted; p < 0.01) had higher urine lead levels than 12-19 year old nonsmokers, most age 
categories did not have an increase in urine lead across the exposure groups. Smokers 12-19 
(unadjusted; p < 0.05), 19-35 (p < 0.001), 35-50 (p < 0.001), 50-65 (p < 0.001), and 65 years and older 
(adjusted; p < 0.05 and unadjusted; p < 0.001) had significantly higher levels than did nonsmokers.  
 
Table 4. Geometric Means and P-values Overall and by Level of Smoke Exposure and 
Demographic Characteristics for Lead (Pb). 
Heavy Metal 
Creatinine 
Adjustment 
Overall  
Geometric 
Mean Pb level 
Nonsmokers Smokers 
P-valuea 
Geometric 
Mean Pb level 
without SHS  
Geometric 
Mean Pb level 
with Low SHS 
Geometric 
Mean Pb level 
with High SHS 
Geometric 
Mean Pb level 
AGE (years) 
2:[6–12)b Adjustedc 0.97 (0.90,1.03) 0.85 (0.77,0.93) 0.89(0.80,0.99)g 1.17(1.03,1.30)h n/ad 0.0005 
  Unadjustede 0.87 (0.79,0.94) 0.78 (0.69,0.87) 0.79 (0.67,0.91) 1.04(0.87,1.20)f  n/a 0.0153 
3:[12–19) Adjusted 0.43 (0.41,0.44) 0.39(0.36,0.42)f 0.48 (0.43,0.53) 0.44 (0.39,0.49) 0.42 (0.38,0.46) 0.0390 
  Unadjusted 0.59 (0.55,0.62) 0.49(0.45,0.54)g 0.67 (0.58,0.77) 0.66 (0.58,0.75) 0.63(0.53,0.73)f 0.0008 
4:[19–35) Adjusted 0.48 (0.45,0.51) 0.42 (0.38,0.46) 0.48 (0.43,0.52) 0.47 (0.40,0.53) 0.56(0.50,0.61)h 0.0005 
  Unadjusted 0.61 (0.56,0.65) 0.48 (0.42,0.54) 0.59 (0.52,0.67) 0.66 (0.52,0.79) 0.76(0.65,0.87)h 0.0001 
5:[ 35–50) Adjusted 0.65 (0.61,0.69) 0.56 (0.51,0.61) 0.59 (0.53,0.65) 0.64(0.54,0.74)g 0.84(0.75,0.94)h 0.0000 
  Unadjusted 0.66 (0.61,0.71) 0.55 (0.50,0.60) 0.64 (0.52,0.77) 0.65 (0.52,0.79) 0.84(0.75,0.93)h 0.0000 
6:[50–65) Adjusted 0.80 (0.75,0.85) 0.72 (0.67,0.78) 0.83 (0.75,0.91) 0.81 (0.67,0.95) 0.96(0.85,1.08)h 0.0002 
  Unadjusted 0.71 (0.64,0.78) 0.62 (0.55,0.68) 0.74 (0.64,0.85) 0.67 (0.42,0.92) 0.94(0.78,1.10)h 0.0001 
7:[65+) Adjusted 0.91 (0.87,0.95) 0.88 (0.83,0.93) 0.92 (0.84,1.00) 0.99 (0.80,1.18) 1.11(0.96,1.26)f 0.0318 
  Unadjusted 0.72 (0.66,0.77) 0.64(0.59,0.70)f 0.81 (0.70,0.92) 0.79 (0.62,0.97) 0.98(0.82,1.15)h 0.0008 
RACE/ETHNICITY  
Non-
Hispanic 
White Adjusted 0.64 (0.62,0.66) 0.59(0.56,0.63)f 0.66 (0.62,0.69) 0.63 (0.57,0.70) 0.71(0.66,0.76)g 0.0011 
  Unadjusted 0.61 (0.58,0.64) 0.54(0.51,0.57)f 0.64 (0.58,0.70) 0.65 (0.55,0.74) 0.72(0.65,0.78)h 0.0001 
Non-
Hispanic 
Black Adjusted 0.66 (0.61,0.71) 0.55 (0.50,0.59) 0.59(0.54,0.64)h 0.73 (0.64,0.82) 0.82(0.71,0.92)h 0.0000 
  Unadjusted 
0.96 (0.89,1.03) 
k 
0.76 
(0.69,0.83)k 
0.83(0.72,0.94)f,
j 
1.04(0.92,1.16)f,
k 
1.34(1.19,1.50)h,
k 0.0000 
Mexican 
American Adjusted 
0.81 
(0.77,0.86)k 
0.79 
(0.75,0.83)k 
0.83 
(0.76,0.91)k 0.79 (0.64,0.93) 0.89 (0.75,1.03)i  
  Unadjusted 
0.87 
(0.81,0.92)k 
0.79 
(0.72,0.85)k 
0.94 
(0.82,1.06)k 0.87 (0.76,0.97)j 
1.13(0.95,1.30)h,
k 0.0002 
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Table 4. Cont. 
GENDER 
Male Adjusted 0.65 (0.62,0.67) 0.56(0.53,0.59)h 0.70 (0.65,0.76) 0.67 (0.59,0.74) 0.73(0.68,0.77)h 0.0000 
  Unadjusted 0.80 (0.76,0.84) 0.69(0.64,0.73)h 0.87 (0.78,0.96) 0.78 (0.65,0.92) 0.95(0.86,1.04)h 0.0000 
Female Adjusted 0.67 (0.64,0.69) 
0.65 
(0.61,0.68)k 0.63 (0.60,0.67)i 0.69 (0.62,0.75) 0.74 (0.67,0.82) 0.0494 
  Unadjusted 
0.58 
(0.55,0.60)k 
0.51 
(0.48,0.54)k 
0.56(0.50,0.61)f,
k 0.70 (0.61,0.79) 
0.70(0.62,0.77)h,
k 0.0000 
POVERTY INDEX 
Below 
poverty index Adjusted 0.74 (0.68,0.79) 0.70 (0.62,0.78) 0.70 (0.61,0.78) 0.81 (0.69,0.94) 0.73 (0.64,0.83)  
  Unadjusted 0.84 (0.78,0.91) 0.68 (0.59,0.77) 0.83 (0.72,0.95) 0.95 (0.81,1.09) 0.93(0.80,1.07)f 0.0015 
Above 
poverty index Adjusted 0.63 (0.61,0.65) 0.59(0.56,0.62)f 0.65 (0.61,0.68) 0.64 (0.58,0.69) 0.72(0.66,0.77)h 0.0007 
  Unadjusted 0.63 (0.61,0.66) 0.56(0.53,0.59)g 0.65 (0.60,0.71) 0.68(0.60,0.77)f 0.78(0.70,0.86)h 0.0000 
a 
A statistically significant difference in log transformed mean levels between the exposure groups 
(nonsmoker, nonsmokerlow, nonsmokerhigh, smoker) determined by linear regression.  
b 
For age categories, a square bracket indicates inclusion of the interval end point, and a parenthesis 
indicates exclusion. 
c 
Units are µg/g creatinine.
  
d 
Not applicable.
 
e 
Units are µg/L. 
For statistical analysis of differences in mean urine metal levels the following t-tests comparisons were 
performed: nonsmokers and nonsmokerslow; nonsmokerslow and nonsmokershigh; nonsmokershigh and 
smokers; smokers and nonsmokers; and nonsmoker vs. nonsmokerhigh for children aged 6–11 years.  
f
 p-value less than 0.05; 
g
 p-value less than 0.01; 
h
 p-value less than 0.001. For statistical analysis of 
differences in mean urine lead levels across group comparisons, the following t-test comparisons were 
performed: non-Hispanic black versus non-Hispanic white, Mexican American versus non-Hispanic 
white, and female versus male. 
i
 p-value less than 0.05; 
j
 p-value less than 0.01; 
k
 p-value less than 0.001.  
 
Both adjusted and unadjusted lead levels were higher in non-Hispanic white (adjusted; p < 0.01 and 
unadjusted p < 0.001) and non-Hispanic black smokers (p < 0.001) than in nonsmokers. Non-Hispanic 
black nonsmokershigh had higher levels than nonsmokerslow (adjusted; p < 0.001 and unadjusted;  
p < 0.05). Only the unadjusted level was higher in Mexican American smokers than nonsmokers  
(p < 0.001). Mexican American nonsmokers did not have an increase in urine lead across the exposure 
groups. 
Across all levels of smoke exposure, non-Hispanic blacks (nonsmokers p < 0.001; nonsmokerslow  
p < 0.01; nonsmokershigh p < 0.001; smokers p < 0.001) and Mexican Americans (nonsmokers  
p < 0.001; nonsmokerslow p < 0.001; nonsmokershigh p < 0.01; smokers p < 0.001) had higher 
unadjusted lead levels than non-Hispanic whites. After adjusting for creatinine content, some 
differences remained among Mexican American nonsmokers (p < 0.001), nonsmokerslow (p < 0.001), 
and smokers (p < 0.05).  
Adjusted and unadjusted lead levels in male smokers were higher than in male nonsmokers  
(p < 0.001). In female smokers, only the unadjusted level was higher than nonsmokers (p < 0.001). In 
general, unadjusted levels were significantly lower in females than males. Female nonsmokers, 
however, had significantly higher adjusted levels than male nonsmokers (p < 0.001). 
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When considering poverty status, adjusted and unadjusted lead levels of smokers above the poverty 
threshold were higher than levels in nonsmokers (p < 0.001). Nonsmokerslow above the poverty 
threshold had higher urine lead levels than nonsmokers above the poverty threshold (adjusted; p < 0.05 
and unadjusted p < 0.01). For smokers below the poverty threshold, only the unadjusted urine lead 
level was higher than the level in nonsmokers (p < 0.05). Nonsmokers below the poverty threshold did 
not have an increase in urine lead across the exposure groups.  
Our findings show that some metals are increased (e.g., cadmium and lead, and antimony and 
barium [unadjusted]) in smokers, while others are lower (e.g., mercury, beryllium, cesium, cobalt, 
molybdenum, platinum, and thallium [adjusted]) or unchanged (tungsten). In general, metals are 
absorbed in the lung, tend to persist in the body with half-lives of years to decades, and most are 
excreted through the kidneys and gastrointestinal tract [22]. So it is plausible that nontrivial exposures 
will be detectable in urine. Consequently, our findings of lower or unchanged urine levels suggest that, 
for the general population, cigarette smoke is not a major environmental source of exposure to 
mercury, beryllium, cesium, cobalt, molybdenum, platinum, thallium, or tungsten. 
Lead and cadmium are emphasized because of their well established toxicity and tendency to 
accumulate in the body [13,14]. It is therefore particularly noteworthy that the highest lead levels were 
among nonsmokershigh 6–12 years, the youngest in our study population. It may be that the youth-adult 
disparity in SHS exposure, which has increased since the early 1990s [9], is contributing to children’s 
lead levels. This hypothesis is supported by others’ observations of high blood lead levels in children 
of smoking parents [3]. It has been suggested that smoking’s contribution to lead levels has become 
increasingly relevant as gasoline lead emissions have declined [3].
 
We found that, with few exceptions, 
adult nonsmokershigh and smokers had similarly high lead levels. Thus, while other potential sources of 
lead exposure were not assessed, our findings suggest that SHS exposure may be sufficient to produce 
a measurable, dose-dependent increase in lead levels. We also observed that only SHS-exposed 
nonsmokers above the poverty threshold had elevated urine lead. This suggests that tobacco smoke is 
an important source of lead exposure for those with higher household income and raises questions 
about other environmental exposures, across income and socioeconomic levels. Future studies of SHS-
exposed children should be designed to address the possible contribution of early childhood 
environmental exposures to lead. 
We also observed high barium and antimony in smokers compared to nonsmokers. As with 
cadmium and lead, barium and antimony are present in cigarette smoke [11,12]. Animal studies 
indicate that inhaled barium is primarily excreted in the feces [23].
 
In contrast, cadmium and absorbed 
lead are eliminated primarily in the urine [13,24]. Although only unadjusted barium was significantly 
elevated, the finding raises mechanistic considerations. For example, the amount of barium received by 
a smoker may exceed the normal renal capacity for tubular reabsorption through common competitive 
transcellular pathways [25] when exposure occurs in the presence of other divalent metals (e.g., 
cadmium). Kidney effects are the most sensitive endpoint following chronic barium exposure in 
laboratory animals [26] and one possible area of research is to investigate barium as a direct renal 
toxicant in smokers.
 
Cadmium and lead are renal toxicants in humans and cadmium urine 
concentrations increase after kidney damage [25,27]. Renal tubular toxicity and low bone density are 
reported at urine cadmium levels as low as 1 µg/g [21,28]. Cadmium levels among older smokers in 
our study approach this level. Consequently, elevated urine barium among smokers may reflect 
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decreased tubular reabsorption in a kidney damaged by exposure to cadmium or other metals. 
Antimony is excreted in the urine and feces [29]. Occupational and animal studies have reported 
respiratory and cardiovascular effects from inhalation of antimony compounds [29]. A recent study 
reported a sharp increase in risk of peripheral artery disease in individuals with low urine antimony 
levels below 0.1 µg/L and a persistent elevated risk above 0.1 µg/L compared with those with urine 
antimony at the limit of detection [7]. In our study, unadjusted urine antimony levels increased across 
exposure groups with smokers having the highest level of 0.13 µg/L. Oxidative stress is proposed to 
play a role in the toxicity and carcinogenicity of some metals (including cadmium, lead, and antimony) 
in tobacco smoke [30].
 
 
There are inverse relations between smoking and levels of important nutrients, independent of 
dietary intake [31]. We observed that smokers had significantly lower cobalt and molybdenum 
(adjusted) than nonsmokers. Our findings are similar to those reported for current vs. former or never 
smokers [32]. While human cobalt deficiencies have not been reported, cobalt is a component of 
vitamin B12 and smoking interferes with absorption of vitamin B12 [32,33]. Molybdenum is a co-factor 
for oxidoreductases such as xanthine oxidase [33]. Molybdenum-deficient soil has been considered a 
possible factor in regions with high rates of esophageal cancer [34,35]. An area of possible research is 
the relation between smoking, reduced levels of essential elements, and smoking-related morbidities 
and co-morbidities. Additional research is needed to determine if smokers have reduced cobalt and 
molybdenum due to dietary deficiencies or independent of other potentially confounding variables. 
Our study is subject to several possible limitations. First, because our nonsmoker definition 
consisted of those that reported not smoking in the last five days, the upper ranges of SHS-exposed 
nonsmokers may include recent quitters and it is also possible that SHS-exposed nonsmokers included 
misidentified occasional smokers whose cotinine levels can overlap with SHS-exposed  
nonsmokers [36]. Dual characterization of nonsmoker status by self-report and serum cotinine 
eliminated nonsmokers with cotinine > 10 ng/mL. If the cotinine measurement condition is omitted 
from our nonsmoker definition, the estimated number of nonsmokers would increase by only 1%. 
Other potential confounders not considered in our analyses are dietary sources of metals, hobbies 
involving metals, lead paint in the home, urban residence, or occupation. Information on some of these 
potential confounders (e.g., hobbies involving metals) is not available for the NHANES population. 
Compared with workers in some industries, however, the prevalence of elevated exposures to metals 
such as lead, cadmium, or antimony in the general population is low and occupational exposure in the 
NHANES population is expected to be rare [7]. Consequently, an assumption in our study is that while 
these potential confounders may differentially impact population groups—in particular those of lower 
socioeconomic status—for lead, the impact is likely minimal given the few variations observed in 
comparisons of those above and below the poverty threshold. Confounding from other potential 
sources of metal exposure should be carefully addressed in studies concerned
 
with causality.  
The representative nature of the data was an important strength as this enables some generalizability 
of the results. For example, we observed higher adjusted cadmium for females for all exposure groups 
and, like others [21], also higher levels in females in the overall sample. Additionally, including 6 
years of data, including the over-sampling of Mexican Americans and non-Hispanic blacks, allowed 
adequate power for race/ethnicity comparisons. We found racial/ethnic differences in cadmium and 
lead. For example, non-Hispanic white nonsmokerslow had higher adjusted cadmium than did non-
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Hispanic blacks or Mexican Americans. Also, nonsmoking Mexican Americans with no or low SHS 
exposure had higher lead than non-Hispanic whites. Non-Hispanic blacks had the highest unadjusted 
lead in the overall sample, amongst nonsmokershigh, and smokers. After adjustment, the differences 
were no longer significant. This observation may be explained by the significantly greater creatinine 
concentrations among non-Hispanic blacks than non-Hispanic whites or Mexican Americans [37].
 
Adjusting for creatinine content resulted in differences across exposure groups becoming significant 
for 6 metals: mercury, beryllium, cesium, cobalt, platinum, and thallium. Presenting both adjusted and 
unadjusted concentrations illustrates the importance of considering the appropriateness of creatinine 
correction based on the study population and the research questions. 
Blood lead measurements are preferred to evaluate lead exposure [21]. Thus, a second limitation of 
the study is that urine lead measurements are more variable than blood levels [21]. It is possible that 
blood lead with less intra-individual variability may show different patterns in smoke-exposed 
individuals. In contrast, urine cadmium is a more reliable measure of chronic cadmium exposure than 
blood cadmium [7]. 
Although our study addresses 12 metals previously reported in tobacco smoke, it is not an 
exhaustive analysis of all metals in tobacco smoke. Data for several toxicologically-important 
chemicals (e.g., chromium, nickel, and arsenic) are not available for all waves of NHANES data in this 
study. Additionally, NHANES urine metals data are not available for children younger than 6 years. 
Finally, the study does not consider co-morbidities such as decreased renal function.  
For some metals (e.g., mercury and thallium), our data suggest that tobacco smoke is not a 
significant source of exposure because levels were higher among nonsmokers than smokers. 
Counterfeit cigarettes can contain higher levels of toxic metals (e.g., cadmium, lead, and thallium) than 
legal cigarettes [38]. Consequently, consumption of counterfeit cigarettes or cigarettes with tobacco 
grown in sludge amended soil may exacerbate the problem [39].  
 
3. Experimental Section 
 
All data were obtained from the NHANES series conducted by the Centers for Disease Control and 
Prevention’s (CDC’s) National Center for Health Statistics (http://www.cdc.gov/nchs/nhanes.htm). 
NHANES is representative of civilian, noninstitutionalized residents of the United States 2 months or 
older. Three waves of NHANES data were included: 1999–2000, 2001–2002, and 2003–2004. The 
analysis file was limited to respondents who completed the health examination component of the 
survey, those with serum cotinine, urine creatinine, and the urine metals antimony, barium, beryllium, 
cadmium, cesium, cobalt, lead, mercury, molybdenum, platinum, thallium, and tungsten 
measurements, and those that responded to tobacco questions. Urine metals were measured for 
participants 6 years or older. The tobacco questions were asked of respondents 12 years or older.  
The final analysis file contained 6,312 respondents with the laboratory measurements, smoker or 
nonsmoker status based on responses to the tobacco questions and serum cotinine levels (further 
described below), and a valid (nonzero) weight variable. The development of the analysis file is 
presented in Figure 1. 
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Figure 1. Analytic sample. 
 
 
Respondents 12 years or older who answered ―No‖ to the question, ―During the past 5 days, did you 
use any product containing nicotine including cigarettes, pipes, cigars, chewing tobacco, snuff, 
nicotine patches, nicotine gum, or any other product containing nicotine‖ were considered nontobacco 
users. Any participant younger than 12 years was considered a nontobacco user, but was excluded if 
their cotinine was ≥ 10 ng/ml because nonsmokers in NHANES have been defined by others [40] as 
persons with serum cotinine < 10 ng/mL. Self-reported nontobacco users 12 years or older with a 
cotinine measurement ≥ 10 ng/mL were also excluded from the analyses. A nonsmoker was defined as 
a self-reported nontobacco user with a cotinine measurement < 10 ng/mL. Nineteen self-reported 
nonsmokers in the final analytic sample had cotinine levels above 10 ng/mL and were excluded.   
Smokers were defined as respondents 12 years or older whose only direct source of nicotine 
exposure was cigarettes. Smokers were those who answered ―Yes‖ to the question, ―During the past 5 
days, did you use any product containing nicotine including cigarettes, pipes, cigars, chewing tobacco, 
snuff, nicotine patches, nicotine gum, or any other product containing nicotine‖ and did not use non-
cigarette sources of nicotine as indicated by answering ―No‖ to additional questions asking if they 
smoked pipes, cigars, used chewing tobacco, snuff or other nicotine products in the past 5 days. 
Smokers that used other non-cigarette sources of nicotine were excluded. 
For cotinine levels below the level of detection, we used an estimated value of 0.035 ng/mL (i.e., 
level of detection, 0.050 ng/mL, divided by the square root of 2) when calculating geometric mean 
urine levels following procedures outlined in previous research [41]. Due to the highly skewed nature 
of cotinine levels in the study population [40], the geometric mean of cotinine, 0.256 ng/mL, was 
chosen as the cutoff point to define low and high SHS exposures. Exposure was categorized into four 
levels: self-identified, unexposed nonsmokers (nonsmokers) — nonsmokers with  
cotinine ≤ 0.035 ng/mL; nonsmokers with low SHS exposure (nonsmokerslow) — nonsmokers with 
cotinine > 0.035 ng/mL and ≤ 0.256 ng/mL; nonsmokers with high SHS exposure (nonsmokershigh) —
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tobacco questions or 
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nonsmokers with cotinine > 0.256 ng/mL and ≤ 10 ng/mL; and smokers—self-identified cigarette 
smokers with cotinine > 10 ng/mL. 146 self-reported smokers in the final analytic sample had cotinine 
levels below 10 ng/mL. 
Participants who described themselves as ―non-Hispanic white,‖ ―non-Hispanic black,‖ and 
―Mexican American‖ were assessed and findings for these racial/ethnic subgroups are presented. 
―Other race/ethnicity,‖ were included in total population estimates but were not presented due to the 
small number of participants in this category. Participant age was categorized into 6 groups: 6–11,  
12–18, 19–34, 35–49, 50–64, and 65 years and older.  
The poverty-to-income ratio (PIR)—the ratio between family income and the poverty threshold, 
based on income thresholds that vary by family size and composition that are updated annually for 
inflation with the Consumer Price Index (U.S. Census Bureau, 2003, 2007) — was used to create a 
dichotomous variable to indicate if the participant was above (> 1.00) or below the poverty threshold  
(< 1.00). The poverty threshold was used as an indicator of socioeconomic status (SES). As reported in 
previous NHANES research [42], poverty is a useful indicator of SES because, unlike other indicators 
of SES like education or occupation, it provides a comparable measure of SES across a broad range of 
ages. 
Biological samples (blood and urine) were collected during a standardized physical examination 
conducted in a mobile examination center (MEC) and stored cold or frozen until laboratory analyses 
were conducted. Serum cotinine was measured by a high-performance liquid 
chromatography/atmospheric-pressure ionization tandem mass spectrometry (LC/MS/MS) method that 
has been described previously [43]. Urine metals were measured by inductively coupled plasma-mass 
spectrometry as described previously [44]. Urine creatinine was measured using an automated 
colorimetric determination based on a modified Jaffe reaction [37]. Further descriptions of sample 
collection and laboratory methods for cotinine, creatinine, and the metals are available at: 
http://www.cdc.gov/nchs/nhanes.htm. Two sets of urine metal measures were created. One is the metal 
concentration adjusted for the creatinine content of the urine (µg/g creatinine) (adjusted). Creatinine 
correction adjusts for urine dilution and is typically performed with spot urine samples [37]. The other 
is the unadjusted urine metal concentration (µg/L) (unadjusted). Creatinine correction is commonly 
used in homogeneous populations; however, multiple demographic groups, such as in this study, 
increase the variability in creatinine levels [37,45]. Cadmium levels in the 1999-2002 data were 
corrected for molybdenum oxide interference. The correction resulted in corrected values less than 
zero being assigned a value of zero (http://www.cdc.gov/nchs/data/nhanes/frequency/ 
lab06hm_doc.pdf). There were 49 cases with zero values in the final analytic sample. All zero values 
were set to missing in the analysis file to insure proper generation of the geometric mean.  
We calculated estimates using the sub-sampling weights to represent nonsmokers ≥ 6 years and 
smokers ≥ 12 years in the United States. In 1999–2002, urine mercury was only measured for females 
16–49 years. Starting in 2003, urine mercury was measured for males and females ≥ 6 years. For 
consistency across all 3 waves of data, the mercury analysis only included data for females  
16–49 years.  
Sampling weights provide population estimates that adjust for unequal probabilities of selection and 
account for nonresponses. The weights were post-stratified to the U.S. population as estimated by the 
Census Bureau. For use with multi-wave data, we calculated analytic survey weight following the 
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NHANES documentation provided on their website. Specifically, this involved taking 2/3 of the 
special four-year MEC weight for 1999-2002 and 1/3 of the two-year MEC weight for 2003-2004. For 
analyses, we used SAS (SAS Institute, Inc., Cary, NC) and SUDAAN (Research Triangle Institute, 
Research Triangle Park, NC)—a program that adjusts for complex sample design when variance 
estimates are calculated. 
Estimates for the geometric mean, with 95% confidence intervals, were calculated by demographic 
characteristic and for each exposure level. A linear regression analysis was then used to identify metals 
whose geometric mean is significantly different between the exposure groups, with log transformations 
of adjusted or unadjusted metal concentrations as the dependent variable and exposure group as the 
independent variable. If an overall difference was significant between the groups, t-tests were 
performed to identify the specific difference(s) for exposure group pairs. T-test comparisons for 
participants 12 years or older were ―nonsmoker vs. nonsmokerlow‖, ―nonsmokerlow vs. nonsmokerhigh‖, 
―nonsmokerhigh vs. smoker‖ and ―nonsmoker vs. smoker‖. For children 6–11 years, t-test comparisons 
were ―nonsmoker vs. nonsmokerlow‖, ―nonsmokerlow vs. nonsmokerhigh‖ and ―nonsmoker vs. 
nonsmokerhigh‖. Additional analyses were performed to examine differences in cadmium or lead levels 
across race/ethnicity and between genders. The comparison reference group for race/ethnicity is non-
Hispanic white and for gender is male. Bonferroni correction was used to control the type I errors on 
multiple comparisons.  
 
4. Conclusions 
 
The U.S. Surgeon General’s recent declaration of no risk-free level of SHS exposure [1] 
underscores the importance of characterizing active and passive exposures to harmful tobacco smoke 
constituents. Some chemicals, notably cadmium and lead, will accumulate in the body. Our findings 
show SHS-exposed children, a population particularly vulnerable to the toxic effects of lead at low 
levels of exposure [15,16] have higher levels of urine lead than children without SHS exposure. Urine 
lead levels respond rapidly to changes in body lead and increase with increasing lead exposure [46] 
and our findings suggest the need for confirmatory study of blood lead levels among SHS exposed 
youth. Older smokers in our study had cadmium levels high enough to raise concerns that they are at 
risk for cadmium-related toxicity. Thus, our findings indicate that active and passive smoking should 
be considered in future investigations to ascertain the role of metals in the disease process. This 
finding is especially relevant for some minorities and socio-economically disadvantaged groups [47]. 
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